Variability in functional p53 reactivation by PRIMA-1(Met)/APR-246 in Ewing sarcoma

BACKGROUND: Though p53 mutations are rare in ES, there is a strong indication that p53 mutant tumours form a particularly bad prognostic group. As such, novel treatment strategies are warranted that would specifically target and eradicate tumour cells containing mutant p53 in this subset of ES patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Aryee, D N T, Niedan, S, Ban, J, Schwentner, R, Muehlbacher, K, Kauer, M, Kofler, R, Kovar, H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Molecular Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833220/
https://www.ncbi.nlm.nih.gov/pubmed/24129240
http://dx.doi.org/10.1038/bjc.2013.635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833220/
https://www.ncbi.nlm.nih.gov/pubmed/24129240
http://dx.doi.org/10.1038/bjc.2013.635

Ejemplares similares